Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AngioDynamics Inc Completes Acquisition of Navilyst Medical


Tuesday, 22 May 2012 09:13am EDT 

AngioDynamics Inc announced that it has completed its acquisition of Navilyst Medical. Based on the closing price of $12.44 on May 21, 2012 the transaction is valued at $355 million. The acquisition and related transaction costs were financed through the issuance of approximately 9.5 million shares of AngioDynamics Common Stock, $150 million in drawn acquisition debt financing, and $97 million of balance sheet cash. To satisfy any working capital adjustment and potential indemnification claims that may arise $20 million of purchase consideration has been placed in escrow. 

Company Quote

14.36
0.39 +2.79%
17 Apr 2014